A share price of Hologic, Inc [HOLX] is currently trading at $78.72, up 0.87%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HOLX shares have gain 1.52% over the last week, with a monthly amount drifted -3.23%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hologic, Inc [NASDAQ: HOLX] stock has seen the most recent analyst activity on October 01, 2024, when Citigroup downgraded its rating to a Neutral and also revised its price target to $85 from $95. Previously, Stephens started tracking the stock with Overweight rating on June 27, 2024, and set its price target to $87. On April 03, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $95 on the stock. Needham upgraded its rating to a Buy but stick to its price target of $95 on July 14, 2023. RBC Capital Mkts initiated its recommendation with a Sector Perform and recommended $75 as its price target on December 07, 2022. Mizuho started tracking with a Buy rating for this stock on October 13, 2022, and assigned it a price target of $75. In a note dated July 20, 2022, UBS initiated an Neutral rating and provided a target price of $73 on this stock.
Hologic, Inc experienced fluctuations in its stock price throughout the past year between $67.59 and $84.67. Currently, Wall Street analysts expect the stock to reach $80.21 within the next 12 months. Hologic, Inc [NASDAQ: HOLX] shares were valued at $78.72 at the most recent close of the market. An investor can expect a potential return of 1.89% based on the average HOLX price forecast.
Analyzing the HOLX fundamentals
Trailing Twelve Months sales for Hologic, Inc [NASDAQ:HOLX] were 4.03B which represents 4.51% growth. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.2%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.16 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 77.79 points at the first support level, and at 76.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.35, and for the 2nd resistance point, it is at 79.97.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hologic, Inc [NASDAQ:HOLX] is 3.69. Further, the Quick Ratio stands at 3.03, while the Cash Ratio is 2.08. Considering the valuation of this stock, the price to sales ratio is 4.54, the price to book ratio is 3.69 and price to earnings (TTM) ratio is 23.68.
Transactions by insiders
Recent insider trading involved Oberton Karleen Marie, Chief Financial Officer, that happened on Aug 29 ’24 when 52679.0 shares were sold. Officer, Oberton Karleen Marie completed a deal on Aug 29 ’24 to buy 52679.0 shares. Meanwhile, Div. President, GYN Surgical Schnittker Brandon sold 476.0 shares on Aug 06 ’24.
